Gross Profit Summary of Doseology Sciences Inc.

Doseology Sciences Inc.'s latest annual gross profit in 2023 was -36.08 Thousand CAD , down -187.4% from previous year.
Doseology Sciences Inc.'s latest quarterly gross profit in 2023 Q4 was 18.5 Thousand CAD , up 170.27% from previous quarter.
Doseology Sciences Inc. reported a annual gross profit of 41.28 Thousand CAD in annual gross profit 2022, up 127.82% from previous year.
Doseology Sciences Inc. reported a annual gross profit of -148.37 Thousand CAD in annual gross profit 2021, down 0.0% from previous year.
Doseology Sciences Inc. reported a quarterly gross profit of -26.32 Thousand CAD for 2023 Q3, down -265.62% from previous quarter.
Doseology Sciences Inc. reported a quarterly gross profit of 28.81 Thousand CAD for 2023 Q1, down -24.85% from previous quarter.

Annual Gross Profit Chart of Doseology Sciences Inc. (2023 - 2019)

Name	Gross Profit	Gross Profit Difference
Algernon Pharmaceuticals Inc.	-50.39 Thousand CAD	28.402%
Asep Medical Holdings Inc	-113.74 Thousand CAD	68.275%
BetterLife Pharma Inc.	- CAD	Infinity%
BioVaxys Technology Corp.	- CAD	Infinity%
ChitogenX Inc.	-42 Thousand CAD	14.086%
Rapid Dose Therapeutics Corp.	563.4 Thousand CAD	106.405%
Defence Therapeutics Inc.	-90.92 Thousand CAD	60.314%
Entheon Biomedical Corp.	250.32 Thousand CAD	114.415%
Gemina Laboratories Ltd.	-93.36 Thousand CAD	61.353%
Glow Lifetech Corp.	-505.62 Thousand CAD	92.863%
Lexston Life Sciences Corp.	-26.39 Thousand CAD	-36.713%
Pharmala Biotech Holdings Inc.	454.09 Thousand CAD	107.946%
MYND Life Sciences Inc.	-332.99 Thousand CAD	89.164%
Nova Mentis Life Science Corp.	25.4 Thousand CAD	242.035%
PharmaTher Holdings Ltd.	-711.00 CAD	-4975.105%
PreveCeutical Medical Inc.	-9856.00 CAD	-266.112%
Telescope Innovations Corp.	595.39 Thousand CAD	106.06%